{"id":225456,"date":"2021-04-12T23:10:04","date_gmt":"2021-04-12T20:10:04","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/aha-issues-statement-on-central-retinal-artery-occlusion\/"},"modified":"2021-04-12T23:10:04","modified_gmt":"2021-04-12T20:10:04","slug":"aha-issues-statement-on-central-retinal-artery-occlusion","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/aha-issues-statement-on-central-retinal-artery-occlusion\/","title":{"rendered":"#AHA issues statement on central retinal artery occlusion"},"content":{"rendered":"

“#AHA issues statement on central retinal artery occlusion<\/strong>”<\/p>\n

\n
\n
\n
\"AHA<\/figure>\n<\/div>\n<\/div>\n

(HealthDay)\u2014Acute central retinal artery occlusion (CRAO) is a medical emergency, and patients should be immedia<\/a>tely triaged to an emergency department for app<\/a>ropriate management, according to a scientific statement issued by the American Heart Association and published online March 8 in Stroke<\/i>.\n <\/p>\n

Brian Mac Grory, M.B., B.Ch., from the Duke Comprehensive Stroke Center at the Duke University School of Medicine in Durham, North Carolina, and colleagues conducted a review of the literature relating to management of CRAO. A panel of experts synthesized the data, submitted considerations for practice, and revised the drafts until consensus was achieved. <\/p>\n

The authors note that acute CRAO is a medical emergency, and immediate triage to an emergency department is necessary. In the setting of CRAO, two additions to the stroke code process are needed: a funduscopic examination to confirm diagnosis and exclude alternative causes, and a screening for arteritis. Sudden, painless, monocular vision loss most often results from CRAO and should be emphasized in public outreach campaigns as a symptom of potential stroke. Treatment with intravenous tissue plasminogen activator is suggested and may be considered for patients who have disabling visual deficits and who meet criteria after a thorough risk-benefit discussion. Secondary prevention should include collaboration between neurology, ophthalmology, and primary care medicine; risk factor modification is recommended for secondary prevention.<\/p>\n

“Central retinal artery occlusion is a cardiovascular problem disguised as an eye problem,” Mac Grory said in a statement. “Unfortunately, a CRAO is a warning sign of other vascular issues, so ongoing follow-up is critical to prevent a future stroke or heart attack.”<\/p>\n

Several authors disclosed financial ties to the pharmaceutical industry.\n <\/p>\n\n

\n

Stroke affecting the eye requires immediate treatment, can signal future vascular events\n <\/p><\/div>\n

\n
\n More information:<\/strong>
\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p><\/div>\n

\n Copyright \u00a9 2021 HealthDay<\/a>. All rights reserved.<\/p>\n

<\/p>\n

\n

Citation<\/strong>:
\n AHA issues statement on central retinal artery occlusion (2021, April 12)
\n retrieved 12 April 2021
\n from https:\/\/medicalxpress.com\/news<\/a>\/2021-04-aha-issues-statement-central-retinal.html<\/p>\n

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
\n part may be reproduced without the written permission. The content is provided for information purposes only.<\/p><\/div>\n<\/p><\/div>\n